Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: results from a pragmatic cluster randomized controlled trial

BMC Cancer

the CIHR/CCMB Team in Primary Care Oncology (PCO-NET)⁶  Gary Crow⁹  Susan McClement⁴  Michelle Lobchuk⁸  Donna Turner³  Jeff Sisler¹  Patricia J Martens²  Alan Katz⁵  Kathleen Clouston⁷ 

[1]Primary Care Oncology Program, CancerCare Manitoba, 675 McDermot Ave, Room ON2038, Winnipeg R3E 0 V9, MB, Canada

[2]Department of Community Health Sciences, Manitoba Centre for Health Policy, Faculty of Medicine, University of Manitoba, 408-727 McDermot Ave, Winnipeg, MB R3E 3P5, Canada

[3]Provincial Director of Population Oncology, CancerCare Manitoba, 675 McDermot Ave, 4th Floor Executive Offices, Winnipeg R3E 0 V9, MB, Canada

[4]Faculty of Nursing, University of Manitoba

[5] CancerCare Manitoba, Office # 3017, 675 Mc Dermot Avenue, Winnipeg R3E 0 V9, MB, Canada

[6]Departments of Family Medicine and Community Health Sciences, Faculty of Medicine, University of Manitoba, P228-770 Bannatyne Ave, Winnipeg, MB R3E 0 W3, Canada

[7]CIHR/CCMB Primary Care Oncology Research Team, 385 Main Street, Winkler, MB R6W 1J2, Canada

[8]Department of Family Medicine Research, Faculty of Medicine, University of Manitoba, 208 Baisinger Drive, Winnipeg R2N 4H7 MB, Canada

[9]Faculty of Nursing, Helen Glass Centre for Nursing, University of Manitoba, Room 315-89 Curry Place, Winnipeg, MB R3T 2 N2, Canada

[10]Faculty of Agriculture, Department of Animal Science, University of Manitoba, 230 Animal Science Building, Winnipeg, MB R3T 2 N2, Canada

关键词: Knowledge exchange;    Integrated knowledge translation;    Patient decision aid;    Pragmatic;    Cluster randomized controlled trial;    Community-based primary healthcare research;    Community-based family practice;    Fecal occult blood test;    Colorectal cancer screening;   

Others  :  858894
DOI  :  10.1186/1471-2407-14-263

 received in 2013-10-02, accepted in 2014-04-09,  发布年份 2014

【 摘 要 】

Background

Evaluation of the effectiveness of a patient decision aid (nurse-managed telephone support line and/or colorectal cancer screening website), distributed to patients by their family physician, in improving fecal occult blood test (FOBT) colorectal cancer screening rates.

Methods

A pragmatic, two arm, cluster randomized controlled trial in Winnipeg, Manitoba, Canada (39 medical clinic clusters; 79 fee-for-service family physicians; 2,395 average risk patients). All physicians followed their standard clinical screening practice. Intervention group physicians provided a fridge magnet to patients that facilitated patient decision aid access. Primary endpoint was FOBT screening rate within four months.

Multi-level logistic regression to determine effect of cluster, physician, and patient level factors on patient FOBT completion rate. ICC determined.

Results

Family physicians were randomized to control (n = 39) and intervention (n = 40) groups. Compared to controls (56.9%; n = 663/1165), patients receiving the intervention had a higher FOBT completion rate (66.6%; n = 805/1209; OR of 1.47; 95% confidence interval 1.06 to 2.03; p < 0.02). Patient aid utilization was low (1.1%; 13/1,221) and neither internet nor telephone access affected screening rates for the intervention group. FOBT screening rates differed among clinics and physicians (p < 0.0001). Patients whose physician promoted the FOBT were more likely to complete it (65%; n = 1140/1755) compared to those whose physician did not (51.1%; n = 242/470; p < 0.0001; OR of 1.54 and 95% CI of 1.23 to 1.92). Patients reporting they had done an FOBT in the past were more likely to complete the test (70.6%; n = 1141/1616; p < 0.0001; 95% CI 2.51 to 3.73) than those who had not (43%; n = 303/705). Patients 50–59 years old had lower screening rates compared to those over 60 (p < 0.0001). 75% of patients completing the test did so in 34 days.

Conclusion

Despite minimal use of the patient aid, intervention group patients were more likely to complete the FOBT. Powerful strategies to increase colorectal cancer screening rates include a recommendation to do the test from the family physician and focusing efforts on patients age 50–59 years to ensure they complete their first FOBT.

Trial registration

Trial registration number: clinicaltrials.gov identifier NCT01026753.

【 授权许可】

   
2014 Clouston et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Canadian Cancer Society: Canadian Cancer Statistics. 2012. http://www.cancer.ca/ webcite
• [2]Hewitson P, Glasziou P, Irwig L, Towler B, Watson E: Screening for colorectal cancer using the fecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007, 24(1):CD001216.
• [3]Flanagan WM, Le Petit C, Berthelot JM, White KJ, Coombs BA, Jones-McLean E: Potential impact of population-based colorectal cancer screening in Canada. Chronic Dis Can 2003, 24(4):81-88.
• [4]Hewitson P, Glasziou P, Watson E, Towler B, Irwig L: Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): An update. Am J Gastroenterol 2008, 103(6):1541-1549.
• [5]Statistics Canada: Study: Mammography use and colorectal cancer testing. 2009. http://www.statcan.gc.ca/daily-quotidien/090630/dq090630c-eng.htm webcite
• [6]PRA Inc: Colorectal cancer screening: Results of a survey of Manitobans 50–74. Manitoba; 2008. http://www.cancercare.mb.ca/resource/File/CRC/Background_ColonCheck_Manitoba_Sept09.pdf webcite
• [7]Canadian Cancer Society: Canadian Cancer Society: Canadian Cancer Statistics, 2011. Toronto; 2011. http://www.cancer.ca webcite
• [8]Canadian Partnership Against Cancer: The 2012 Cancer System Performance Report. 2012. http://www.partnershipagainstcancer.ca/wp-content/uploads/The-2012-Cancer-System-Performance-Report.pdf webcite
• [9]Canadian Partnership Against Cancer: Colorectal Cancer Screening in Canada: Current Facts and Resources. 2010. http://www.cancerview.ca/idc/groups/public/documents/webcontent/rl_crc_snapshot_one_en.pdf webcite
• [10]Stokamer CL, Tenner CT, Chaudhuri J, Vazquez E, Bini EJ: Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing. J Gen Intern Med 2005, 20(3):278-282.
• [11]Fortin M, Lapointe L, Hudon C, Vanasse A: Multimorbidity is common to family practice: is it commonly researched? Can Fam Physician 2005, 51:244-245.
• [12]Fortin M, Bravo G, Hudon C, Vanasse A, Lapointe L: Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med 2005, 3:223-228.
• [13]Yarnall KS, Pollak KI, Østbye T, Krause KM, Michener LJ: Priamry Care: Is there enough time for prevention? Am J Public Health 2003, 93(4):635-641.
• [14]Miller DP, Kimberly JR, Case LD, Wofford JL: Using a computer to teach patients about fecal occult blood screening. J Gen Intern Med 2005, 20(11):984-988.
• [15]Statistics Canada: CANSIM table 358–0130. http://www.statcan.gc.ca/ webcite
• [16]Botting I, Katz A, the Provincial health Contact Centre Congestive Heart Failure Committee Winnipeg Regional Health Authority, Research Evaluation Unit: Research Evaluation Unit. Moving Forward In Integrating Chronic Disease Management With Primary Care: A Summary Of Qualitative Findings From The Chronic Disease Management Of Congestive Heart Failure Via Health Lines Demonstration Project. 2009.
• [17]Crespi CM, Maxwell AE, Wu S: Cluster randomized trials of cancer screening interventions: are appropriate statistical methods being used? Contempary Clin Trials 2011, 32(4):477-484.
• [18]Sisler J, McCormack-Speak P: Bridging the gap between primary care and the cancer system. Can Fam Physician 2009, 55(3):273-278.
• [19]Hintze J, NCSS and PASS: Number Cruncher Statistical Systems. Kaysville, Utah; 2001. http://www.ncss.com webcite
• [20]Campbell MK, Thomsom S, Ramsay CR, MacLennan GS, Grimshaw JM: Sample size calculator for cluster randomized trials. Comput Biol Med 2004, 34:113-125.
• [21]Clouston K, Katz A, Martens PJ, Sisler J, Turner D, Lobchuk M, McClement S, the CIHR/CCMB Team in Primary Care Oncology (PCO-NET): Does a colorectal cancer screening patient aid provided by family physicians increase colorectal cancer screening rates?: a pragmatic cluster randomized controlled trial study protocol. BMC Cancer 2012, 12:182. http://www.ncbi.nlm.nih.gov/pubmed/22607726 webcite BioMed Central Full Text
• [22]Christie J, O’Halloran P, Stevenson M: Planning a cluster randomized controlled trial: methodological issues. Nurs Res 2009, 58(2):128-134.
• [23]Schulz KF, Altman DG, Moher D, for the CONSORT Group: CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c332.
• [24]Adams AS, Soumerui SB, Lomas J, Ross-Degnan D: Evidence of self-report bias in assessing adherence to guidelines. Int J Qual Health Care 1999, 11(3):187-192.
• [25]Montaño DE, Phillips WR: Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J Public Health Nations Health June 1995, 85(6):795-800.
• [26]Holden DJ, Jonas DE, Porterfield DS, Reuland D, Harris R: Systematic Review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med 2010, 152(10):668-676.
• [27]Steele RJC, Kostouru I, McClements P, Watling C, Libby G, Weller D, Brewster DH, Black R, Carey FA, Fraser C: Effects of age, gender and deprivation on key performance indicators in a FOBT based colorectal cancer screening programme. J Med Screen 2010, 17:68-74.
• [28]Physician Integrated Network http://www.gov.mb.ca/health/phc/pin/index.html webcite